Minimal risk of lymphoma and non-melanoma skin cancer despite long-term use of thiopurines in patients with inflammatory bowel disease: A longitudinal cohort analysis from northern India.
Mukesh Kumar RanjanBhaskar KanteSudheer Kumar VuyyuruPeeyush KumarSandeep K MundhraRithvik GollaRaju SharmaPeush SahniPrasenjit DasGovind Kumar MakhariaSaurabh KediaVineet AhujaPublished in: Journal of gastroenterology and hepatology (2022)
Long-term follow up of patients with IBD from northern India on thiopurine monotherapy demonstrated minimal risk of development of lymphoma as well as non-melanoma skin cancer.